Obstetrics and Gynaecology - Research Publications

Permanent URI for this collection

http://hdl.handle.net/11343/208

Filters

2020 - 2022 4
3 1
Reset filters

Settings
Statistics
Citations
Start date: 2020 × End date: 2022 × Author: Hickey, Martha × Author: Saunders, Christobel ×

Search Results

Now showing 1 - 4 of 4
  • Item
    Thumbnail Image
    Surviving and thriving after breast cancer treatment
    Saunders, CM ; Stafford, L ; Hickey, M (WILEY, 2022-09-05)
  • Item
    Thumbnail Image
    Motivators of Inappropriate Ovarian Cancer Screening: A Survey of Women and Their Clinicians
    Macdonald, C ; Mazza, D ; Hickey, M ; Hunter, M ; Keogh, LA ; Jones, SC ; Saunders, C ; Nesci, S ; Milne, RL ; Mclachlan, S-A ; Hopper, JL ; Friedlander, ML ; Emery, J ; Phillips, K-A (OXFORD UNIV PRESS, 2021-02)
    BACKGROUND: This study examined why women and doctors screen for ovarian cancer (OC) contrary to guidelines. METHODS: Surveys, based on the Theoretical Domains Framework, were sent to women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer and family physicians and gynecologists who organized their screening. RESULTS: Of 1264 Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer women, 832 (65.8%) responded. In the past 2 years, 126 (15.1%) had screened. Most of these (n = 101, 80.2%) would continue even if their doctor told them it is ineffective. For women, key OC screening motivators operated in the domains of social role and goals (staying healthy for family, 93.9%), emotion and reinforcement (peace of mind, 93.1%), and beliefs about capabilities (tests are easy to have, 91.9%). Of 531 clinicians 252 (47.5%) responded; a minority (family physicians 45.8%, gynecologists 16.7%) thought OC screening was useful. For gynecologists, the main motivators of OC screening operated in the domains of environmental context (lack of other screening options, 27.6%), and emotion (patient peace of mind, 17.2%; difficulty discontinuing screening, 13.8%). For family physicians,, the strongest motivators were in the domains of social influence (women ask for these tests, 20.7%), goals (a chance these tests will detect cancer early, 16.4%), emotion (patient peace of mind, 13.8%), and environmental context (no other OC screening options, 11.2%). CONCLUSION: Reasons for OC screening are mostly patient driven. Clinician knowledge and practice are discordant. Motivators of OC screening encompass several domains, which could be targeted in interventions to reduce inappropriate OC screening.
  • Item
    Thumbnail Image
    The cognitive, affective, social and environmental drivers of inappropriate ovarian cancer screening: A survey of women and their clinicians using the theoretical domains framework
    Macdonald, C ; Mazza, D ; Hickey, M ; Hunter, M ; Keogh, LA ; Jones, SC ; Saunders, C ; Nesci, S ; Milne, RL ; McLachlan, SA ; Hopper, J ; Friedlander, M ; Emery, J ; Phillips, KA (ELSEVIER, 2020-09)
  • Item
    Thumbnail Image
    Exploring the facilitators and barriers to using an online infertility risk prediction tool (FoRECAsT) for young women with breast cancer: a qualitative study protocol.
    Edib, Z ; Jayasinghe, Y ; Hickey, M ; Stafford, L ; Anderson, RA ; Su, HI ; Stern, K ; Saunders, C ; Anazodo, A ; Macheras-Magias, M ; Chang, S ; Pang, P ; Agresta, F ; Chin-Lenn, L ; Cui, W ; Pratt, S ; Gorelik, A ; Peate, M (BMJ Journals, 2020-02-10)
    INTRODUCTION: As cancer treatments may impact on fertility, a high priority for young patients with breast cancer is access to evidence-based, personalised information for them and their healthcare providers to guide treatment and fertility-related decisions prior to cancer treatment. Current tools to predict fertility outcomes after breast cancer treatments are imprecise and do not offer individualised prediction. To address the gap, we are developing a novel personalised infertility risk prediction tool (FoRECAsT) for premenopausal patients with breast cancer that considers current reproductive status, planned chemotherapy and adjuvant endocrine therapy to determine likely post-treatment infertility. The aim of this study is to explore the feasibility of implementing this FoRECAsT tool into clinical practice by exploring the barriers and facilitators of its use among patients and healthcare providers. METHODS AND ANALYSIS: A cross-sectional exploratory study is being conducted using semistructured in-depth telephone interviews with 15-20 participants each from the following groups: (1) premenopausal patients with breast cancer younger than 40, diagnosed within last 5 years, (2) breast surgeons, (3) breast medical oncologists, (4) breast care nurses (5) fertility specialists and (6) fertility preservation nurses. Patients with breast cancer are being recruited from the joint Breast Service of three affiliated institutions of Victorian Comprehensive Cancer Centre in Melbourne, Australia-Peter MacCallum Cancer Centre, Royal Melbourne Hospital and Royal Women's Hospital, and clinicians are being recruited from across Australia. Interviews are being audio recorded, transcribed verbatim and imported into qualitative data analysis software to facilitate data management and analyses. ETHICS AND DISSEMINATION: The study protocol has been approved by Melbourne Health Human Research Ethics Committee, Australia (HREC number: 2017.163). Confidentiality and privacy are maintained at every stage of the study. Findings will be disseminated through peer-reviewed scholarly and scientific journals, national and international conference presentations, social media, broadcast media, print media, internet and various community/stakeholder engagement activities.